prolaio eVO2peak Module vs Study Watch
AI Verdict
Choose prolaio eVO2peak Module if…
Choose Prolaio eVO2peak Module if your primary need is to estimate peak oxygen consumption (eVO2peak) for cardiovascular research or clinical evaluation. This software is ideal for leveraging data from existing qualified third-party FDA-cleared wearable medical sensors, providing an adjunctive aid without requiring a new dedicated monitoring device.
View prolaio eVO2peak Module →Choose Study Watch if…
Choose Verily Study Watch if your clinical research requires direct, continuous, and multi-sensor physiological monitoring from a dedicated wearable device. This prescription-only watch is best suited for studies needing to collect comprehensive, raw physiological data like ECG, heart rate, and movement for analysis within Verily's integrated cloud platform.
View Study Watch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | prolaio eVO2peak Module | Study Watch |
|---|---|---|
| Deployment | Cloud | The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
prolaio eVO2peak ModuleProlaio offers a patient-facing mobile app that guides users through data collection and provides feedback, and it supplies a comprehensive kit including a pre-loaded phone and various connected devices for ease of use. This holistic approach to patient engagement and data input suggests a more streamlined and supported user experience compared to the Verily Study Watch, which is a dedicated research device with limited on-device data viewing for patients.
Clinical Value
Study WatchWhile Tool A provides a specific, FDA-cleared estimation of eVO2peak for cardiovascular evaluation, Tool B offers a broader clinical value through its continuous physiological monitoring capabilities. It is FDA-cleared for single-channel ECG and irregular pulse monitoring (AFib detection), and is actively used in clinical research across multiple specialties, including Parkinson's disease, heart failure risk, and sleep monitoring, demonstrating a wider range of direct and research-driven clinical applications.
Pricing & Value
TieNeither tool provides publicly available pricing information, making it impossible to conduct a head-to-head comparison of their cost or assess their relative value proposition. Both are enterprise-grade solutions that require direct contact for pricing details.
Enterprise Readiness
prolaio eVO2peak ModuleBoth tools demonstrate strong enterprise readiness with FDA clearance, cloud deployment, and HIPAA compliance claims. However, Tool B faces an ongoing lawsuit alleging HIPAA violations, which, despite denials, introduces a potential compliance risk that Tool A does not explicitly share, making Tool A a more secure choice for enterprise adoption. [cite: JSON]
Innovation
prolaio eVO2peak ModuleTool A demonstrates significant innovation through its proprietary, locked deep-learning model that estimates peak oxygen consumption (eVO2peak) by integrating diverse data from qualified third-party FDA-cleared wearable medical sensors. This represents a novel application of AI to derive a complex, high-value clinical biomarker from potentially existing and varied data streams.
Support & Docs
Study WatchVerily provides a dedicated and publicly accessible support section on its website, offering product documentation, tutorials, and resources for its platforms, including regulatory information for the Study Watch. While Tool A mentions 'always-on support' for patients and technical support for studies, Tool B's structured and documented support resources appear more comprehensive.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | prolaio eVO2peak Module | Study Watch |
|---|---|---|
| Name | prolaio eVO2peak Module | Study Watch |
| Company | Prolaio | Verily Life Sciences |
| Description | Prolaio is a clinical intelligence company that develops FDA-cleared software, such as the eVO2peak Module, to estimate peak oxygen consumption using real-world patient data for cardiovascular research and care. | Verily Study Watch is a prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. |
| Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Key Features | Estimates peak oxygen consumption (eVO2peak), Utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs, Processes data from qualified third-party FDA-cleared wearable medical sensors, Applies a locked deep-learning model for eVO2peak estimation, Provides information as an adjunctive aid in clinical evaluation, Enables high-density, longitudinal data collection, Leverages real-world patient data and insights, Features FDA-cleared software and proprietary algorithms | Continuous physiological monitoring, Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements), Long battery life (up to one week), Internal data storage and encryption, Cloud-based data processing with algorithms and machine learning, On-demand single-channel ECG, Irregular pulse monitor, E-ink display for minimal power consumption |
Videos
Demos, reviews, and walkthroughs featuring prolaio eVO2peak Module and Study Watch.